Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Bhatia

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of the American Academy of Dermatology|February 16, 2018
An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgarisNeal D Bhatia
The Journal of Clinical and Aesthetic Dermatology|November 25, 2010
Update on vaccines in dermatology - part 1: human papillomavirus vaccineNeal D Bhatia
The Journal of Clinical and Aesthetic Dermatology|January 3, 2022
Medical Photography in the Age of Smartphone CamerasDaniel M Siegel, Neal D Bhatia
Journal of Drugs in Dermatology : JDD|July 11, 2012
Optimal management of papulopustular rosacea: rationale for combination therapyNeal D Bhatia, James Q Del Rosso
Cutis|September 11, 2020
Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black populationNeal D Bhatia, William P Werschler, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|October 5, 2019
Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower ExtremitiesNeal D. Bhatia, Tracey C. Vlahovic, Lawrence G. Green, et al.
Journal of Drugs in Dermatology : JDD|January 18, 2017
The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin BarrierHilary E Baldwin, Neal D Bhatia, Adam Friedman, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% CreamNeal D Bhatia, David M Pariser, Leon Kircik, et al.
The Journal of Clinical and Aesthetic Dermatology|November 29, 2021
Nonantibiotic Properties of Tetracyclines in Rosacea and Their Clinical ImplicationsJames Q Del Rosso, Guy Webster, Jonathan S Weiss, et al.
The Journal of Clinical and Aesthetic Dermatology|December 7, 2020
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular RosaceaLinda Stein Gold, James Q Del Rosso, Leon Kircik, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of the American Academy of Dermatology|February 16, 2018
An open-label exploratory study evaluating the efficacy and safety of ingenol mebutate gel 0.05% for the treatment of verruca vulgarisNeal D Bhatia
The Journal of Clinical and Aesthetic Dermatology|November 25, 2010
Update on vaccines in dermatology - part 1: human papillomavirus vaccineNeal D Bhatia
The Journal of Clinical and Aesthetic Dermatology|January 3, 2022
Medical Photography in the Age of Smartphone CamerasDaniel M Siegel, Neal D Bhatia
Journal of Drugs in Dermatology : JDD|July 11, 2012
Optimal management of papulopustular rosacea: rationale for combination therapyNeal D Bhatia, James Q Del Rosso
Cutis|September 11, 2020
Tolerability of tretinoin lotion 0.05% for moderate to severe acne vulgaris: a post hoc analysis in a black populationNeal D Bhatia, William P Werschler, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|October 5, 2019
Halobetasol 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis of the Lower ExtremitiesNeal D. Bhatia, Tracey C. Vlahovic, Lawrence G. Green, et al.
Journal of Drugs in Dermatology : JDD|January 18, 2017
The Role of Cutaneous Microbiota Harmony in Maintaining a Functional Skin BarrierHilary E Baldwin, Neal D Bhatia, Adam Friedman, et al.
The Journal of Clinical and Aesthetic Dermatology|December 28, 2018
Safety and Efficacy of a Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination Lotion in the Treatment of Moderate-to-severe Plaque Psoriasis: A Comparison with Halobetasol Propionate 0.05% CreamNeal D Bhatia, David M Pariser, Leon Kircik, et al.
The Journal of Clinical and Aesthetic Dermatology|November 29, 2021
Nonantibiotic Properties of Tetracyclines in Rosacea and Their Clinical ImplicationsJames Q Del Rosso, Guy Webster, Jonathan S Weiss, et al.
The Journal of Clinical and Aesthetic Dermatology|December 7, 2020
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular RosaceaLinda Stein Gold, James Q Del Rosso, Leon Kircik, et al.
Pageof 2